Dogwood Therapeutics (DWTX) Net Shares Issued and Repurchased (2020 - 2026)

Dogwood Therapeutics has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $657500.0 in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $657500.0 in Q1 2026; TTM through Mar 2026 was $657500.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.0 million, up 6818.06% from the prior year.
• Net Shares Issued and Repurchased was $657500.0 for Q1 2026 at Dogwood Therapeutics, down from $1.0 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $1.0 million in Q4 2025, with the low at $1260.0 in Q4 2023.
• Average Net Shares Issued and Repurchased over 5 years is $419096.4, with a median of $292500.0 recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased slumped 99.86% in 2023, then surged 6818.06% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $912500.0 in 2022, then plunged by 99.86% to $1260.0 in 2023, then jumped by 1092.94% to $15031.0 in 2024, then soared by 6818.06% to $1.0 million in 2025, then plunged by 36.77% to $657500.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $657500.0 (Q1 2026), $1.0 million (Q4 2025), and $15031.0 (Q4 2024), per Business Quant data.